Imprimis Pharmaceuticals Inc. (IMMY) News Nov 20,
Post# of 250602
Posted On: 11/20/2014 8:51:33 PM
Imprimis Pharmaceuticals Inc. (IMMY) News Nov 20, 2014, 3:59 p.m.
MarketWatch News on IMMY
No News currently available for IMMY
Other News on IMMY
Imprimis Pharmaceuticals' (IMMY) CEO Mark Baum on Q3 2014 Results -- Earnings Call Transcript 8:28 p.m. Nov. 12, 2014 - Seeking Alpha
10-Q: IMPRIMIS PHARMACEUTICALS, INC. 4:06 p.m. Nov. 12, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-K: IMPRIMIS PHARMACEUTICALS, INC. 3:34 p.m. March 28, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-Q: IMPRIMIS PHARMACEUTICALS, INC. 8:08 a.m. Nov. 6, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-Q: IMPRIMIS PHARMACEUTICALS, INC. 5:06 p.m. Aug. 14, 2013 - Edgar Online - (EDG = 10Q, 10K)
Imprimis Management Discovers And Adds Significant Value In Bankrupt Company Restart 7:29 a.m. July 9, 2013 - Seeking Alpha
Imprimis' Platform Set To Bring Library Drug Formulations Quickly To Market 7:01 a.m. May 30, 2013 - Seeking Alpha
Press Releases on IMMY
Imprimis Pharmaceuticals to Host its Third Quarter 2014 Financial Report Conference Call and Webcast on November 12, 2014 8:00 a.m. Nov. 6, 2014 - PR Newswire - PRF
Imprimis Pharmaceuticals Signs Distribution Agreement to Bring Go Dropless™ Proprietary Formulations to Ophthalmologists in Puerto Rico 8:00 a.m. Nov. 4, 2014 - PR Newswire - PRF
Imprimis Pharmaceuticals Enters into License Agreement for Patented Urology Formulation 7:31 a.m. Oct. 29, 2014 - PR Newswire - PRF
Imprimis Pharmaceuticals Reports on Positive Clinical Findings Presented at the American Academy of Ophthalmology (AAO) Annual Meeting 7:00 a.m. Oct. 24, 2014 - PR Newswire - PRF
Imprimis Pharmaceuticals to Present at Craig-Hallum Alpha Select Conference 7:00 a.m. Sept. 16, 2014 - PR Newswire - PRF
Imprimis Pharmaceuticals Appoints Healthcare Leader William H. Nelson to its Board of Directors 7:00 a.m. Sept. 8, 2014 - PR Newswire - PRF
Imprimis Pharmaceuticals Announces Second Quarter 2014 Financial Results and Provides Operational Update 3:30 p.m. Aug. 13, 2014 - PR Newswire - PRF
Imprimis Pharmaceuticals' Go Dropless™ Cataract Surgery Formulations to be Featured in Two Sessions at the 2014 American-European Congress of Ophthalmic Surgery (AECOS) Summer Symposium 7:00 a.m. July 24, 2014 - PR Newswire - PRF
Imprimis Pharmaceuticals Go Dropless™ Video Interview Survey Reveals 95% of Leading Cataract Surgeons Surveyed Would Prefer Dropless Therapy 7:00 a.m. June 24, 2014 - PR Newswire - PRF
Imprimis Pharmaceuticals to Exhibit Go Dropless™ Cataract Surgery Formulations at 2014 Kiawah Eye Meeting 7:00 a.m. May 28, 2014 - PR Newswire - PRF
Imprimis Pharmaceuticals' Go Dropless™ Cataract Surgery Formulations to be Presented in Two Sessions at the 2014 American Society of Cataract and Refractive Surgery (ASCRS) Annual Symposium & Congress 7:00 a.m. April 22, 2014 - PR Newswire - PRF
Imprimis Pharmaceuticals Scheduled to Present at 13th Annual Needham Healthcare Conference 5:00 a.m. March 25, 2014 - PR Newswire - PRF
Imprimis Pharmaceuticals Announces Participation at Two Upcoming Investor Conferences 6:00 a.m. March 4, 2014 - PR Newswire - PRF
Imprimis Pharmaceuticals' Pre-Commercial Ophthalmic Formulations to be Presented at 2014 American-European Congress of Ophthalmic Surgery (ACOS™)/Dulaney Winter Meeting 6:00 a.m. Feb. 25, 2014 - PR Newswire - PRF
Imprimis Pharmaceuticals Names Pharmacy Business Leader Randle House as Vice President of Pharmacy Operations 6:00 a.m. Feb. 19, 2014 - PR Newswire - PRF
Imprimis Pharmaceuticals Announces Acquisition of Pharmacy Creations, Empowering Company to Make and Distribute its Patent-Pending Proprietary Formulations 6:00 a.m. Feb. 11, 2014 - PR Newswire - PRF
Imprimis Pharmaceuticals to Exhibit Pre-Commercial Ophthalmic Formulations At 2014 ACES/SEE Caribbean Eye Meeting 6:00 a.m. Jan. 28, 2014 - PR Newswire - PRF
Imprimis Pharmaceuticals Announces Plans to Pursue Compounding Pharmacy Strategy in Accordance with the Recently Passed Drug Quality and Security Act 8:00 a.m. Dec. 9, 2013 - PR Newswire
Imprimis Optimistic After Congressional Passage of the Drug Quality and Security Act 8:00 a.m. Nov. 19, 2013 - PR Newswire
Imprimis Pharmaceutical Names Seasoned Ophthalmology Executive John Saharek as Vice-President of Commercialization for its Ophthalmology Division 8:00 a.m. Nov. 12, 2013 - PR Newswire
MarketWatch News on IMMY
No News currently available for IMMY
Other News on IMMY
Imprimis Pharmaceuticals' (IMMY) CEO Mark Baum on Q3 2014 Results -- Earnings Call Transcript 8:28 p.m. Nov. 12, 2014 - Seeking Alpha
10-Q: IMPRIMIS PHARMACEUTICALS, INC. 4:06 p.m. Nov. 12, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-K: IMPRIMIS PHARMACEUTICALS, INC. 3:34 p.m. March 28, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-Q: IMPRIMIS PHARMACEUTICALS, INC. 8:08 a.m. Nov. 6, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-Q: IMPRIMIS PHARMACEUTICALS, INC. 5:06 p.m. Aug. 14, 2013 - Edgar Online - (EDG = 10Q, 10K)
Imprimis Management Discovers And Adds Significant Value In Bankrupt Company Restart 7:29 a.m. July 9, 2013 - Seeking Alpha
Imprimis' Platform Set To Bring Library Drug Formulations Quickly To Market 7:01 a.m. May 30, 2013 - Seeking Alpha
Press Releases on IMMY
Imprimis Pharmaceuticals to Host its Third Quarter 2014 Financial Report Conference Call and Webcast on November 12, 2014 8:00 a.m. Nov. 6, 2014 - PR Newswire - PRF
Imprimis Pharmaceuticals Signs Distribution Agreement to Bring Go Dropless™ Proprietary Formulations to Ophthalmologists in Puerto Rico 8:00 a.m. Nov. 4, 2014 - PR Newswire - PRF
Imprimis Pharmaceuticals Enters into License Agreement for Patented Urology Formulation 7:31 a.m. Oct. 29, 2014 - PR Newswire - PRF
Imprimis Pharmaceuticals Reports on Positive Clinical Findings Presented at the American Academy of Ophthalmology (AAO) Annual Meeting 7:00 a.m. Oct. 24, 2014 - PR Newswire - PRF
Imprimis Pharmaceuticals to Present at Craig-Hallum Alpha Select Conference 7:00 a.m. Sept. 16, 2014 - PR Newswire - PRF
Imprimis Pharmaceuticals Appoints Healthcare Leader William H. Nelson to its Board of Directors 7:00 a.m. Sept. 8, 2014 - PR Newswire - PRF
Imprimis Pharmaceuticals Announces Second Quarter 2014 Financial Results and Provides Operational Update 3:30 p.m. Aug. 13, 2014 - PR Newswire - PRF
Imprimis Pharmaceuticals' Go Dropless™ Cataract Surgery Formulations to be Featured in Two Sessions at the 2014 American-European Congress of Ophthalmic Surgery (AECOS) Summer Symposium 7:00 a.m. July 24, 2014 - PR Newswire - PRF
Imprimis Pharmaceuticals Go Dropless™ Video Interview Survey Reveals 95% of Leading Cataract Surgeons Surveyed Would Prefer Dropless Therapy 7:00 a.m. June 24, 2014 - PR Newswire - PRF
Imprimis Pharmaceuticals to Exhibit Go Dropless™ Cataract Surgery Formulations at 2014 Kiawah Eye Meeting 7:00 a.m. May 28, 2014 - PR Newswire - PRF
Imprimis Pharmaceuticals' Go Dropless™ Cataract Surgery Formulations to be Presented in Two Sessions at the 2014 American Society of Cataract and Refractive Surgery (ASCRS) Annual Symposium & Congress 7:00 a.m. April 22, 2014 - PR Newswire - PRF
Imprimis Pharmaceuticals Scheduled to Present at 13th Annual Needham Healthcare Conference 5:00 a.m. March 25, 2014 - PR Newswire - PRF
Imprimis Pharmaceuticals Announces Participation at Two Upcoming Investor Conferences 6:00 a.m. March 4, 2014 - PR Newswire - PRF
Imprimis Pharmaceuticals' Pre-Commercial Ophthalmic Formulations to be Presented at 2014 American-European Congress of Ophthalmic Surgery (ACOS™)/Dulaney Winter Meeting 6:00 a.m. Feb. 25, 2014 - PR Newswire - PRF
Imprimis Pharmaceuticals Names Pharmacy Business Leader Randle House as Vice President of Pharmacy Operations 6:00 a.m. Feb. 19, 2014 - PR Newswire - PRF
Imprimis Pharmaceuticals Announces Acquisition of Pharmacy Creations, Empowering Company to Make and Distribute its Patent-Pending Proprietary Formulations 6:00 a.m. Feb. 11, 2014 - PR Newswire - PRF
Imprimis Pharmaceuticals to Exhibit Pre-Commercial Ophthalmic Formulations At 2014 ACES/SEE Caribbean Eye Meeting 6:00 a.m. Jan. 28, 2014 - PR Newswire - PRF
Imprimis Pharmaceuticals Announces Plans to Pursue Compounding Pharmacy Strategy in Accordance with the Recently Passed Drug Quality and Security Act 8:00 a.m. Dec. 9, 2013 - PR Newswire
Imprimis Optimistic After Congressional Passage of the Drug Quality and Security Act 8:00 a.m. Nov. 19, 2013 - PR Newswire
Imprimis Pharmaceutical Names Seasoned Ophthalmology Executive John Saharek as Vice-President of Commercialization for its Ophthalmology Division 8:00 a.m. Nov. 12, 2013 - PR Newswire
(0)
(0)Scroll down for more posts ▼